20/12/2013
Report no. 113/2013
Conclusion of a significant agreement with CareUp BV – the Final agreement to take up Series H shares
Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodic information provided by issuers of securities, the Management Board of EMC Instytut Medyczny SA informs that on 19 December 2013 a final agreement was signed with CareUp BV ("CareUp"), the existing shareholder of the Company, to take up Series H shares.
Whereas on 19 December 2013 the resolution no 39/2013 to increase the share capital from PLN 33,308,856.00 to PLN 48,078,096.00 by way of issue of 3,692,310 ordinary bearer Series H shares, the issue price PLN 19,50 per share and to exclude the preemptive rights of the existing shareholders as well as offering the issued shares in a private placement to the Shareholder was adopted by the General Meeting of EMC Instytut Medyczny SA- the final agreement was entered onto by the Parties.
The Company informed about the preliminary agreement to take up shares concluded with CareUp in its current report no. 109/2013 announced on 19.12.2013.
The Company informed about the resolutions adopted by the EGM in its current report no. 111/2013 of 19.12.2013.
In the Final agreement to take up shares the Parties have agreed as follows:
1. The Company shall offer CareUp to take up 2,743,940 ordinary bearer series H shares of nominal value PLN 4 per share and the issue price PLN 19,50 per share under private placement , while CareUp shall take up the above shares at the above issue price. The cash contribution shall be made by the Shareholder to the bank account of the Company.
2. Shares documents shall be issued to CareUp within 5 days from the date of submitting the requests by CareUp after the the increase in the share capital has been registered pursuant to the Resolution.
The value of this contract is PLN 53,506,830.00.
No contractual penalties have been laid down in the contract. A criterion for a contract to be considered significant: The value of contracts exceeds 10% of the Issuer’s equity capital.